Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study-Reference-Cited by-同舟云学术

Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study

Published:2018-05-07 Issue:10 Volume:35 Page:946-952
ISSN:1091-4269
Container-title:Depression and Anxiety
language:en
Short-container-title:Depress Anxiety

Author:

Perlis Roy H.¹^ORCID,Mehta Rajesh²,Edwards Alison M.²,Tiwari Arun²,Imbens Guido W.³

Affiliation:

1. Center for Quantitative Health; Division of Clinical Research; Massachusetts General Hospital and Harvard Medical School; Boston MA USA

2. Healthagen; New York City NY USA

3. Graduate School of Business; Stanford University; Stanford CA USA

Funder

Genomind

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/da.22742/fullpdf

Reference16 articles.

1. Agency for Healthcare Research And Quality 2008 National Healthcare Quality Report https://archive.ahrq.gov/research/findings/nhqrdr/nhqr08/index.html

2. A naturalistic study of the effectiveness of pharmacogenetic testing to guide treatment in psychiatric patients with mood and anxiety disorders;Brennan;The Primary Care Companion for CNS Disorders,2015

3. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings;Fagerness;The American Journal of Managed Care,2014

4. Federal Drug Administration 2016 Table of pharmacogenomic biomarkers in drug labeling https://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm

5. USQA Health Profile Database as a tool for health plan quality improvement;Hanchak;Management Care Quarterly,1996

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals;International Journal of Molecular Sciences;2024-07-22

3. Exploring biologically oriented precision mental health initiatives for the care of patients with eating disorders: A narrative review;European Eating Disorders Review;2024-06-12

4. The Contribution of Genetic Testing in Optimizing Therapy for Patients with Recurrent Depressive Disorder;Clinics and Practice;2024-04-23

5. The role of pharmacogenetics in the treatment of major depressive disorder: a critical review;Frontiers in Psychiatry;2023-11-10